CBD shows promising anti-inflammatory and cardioprotective properties in preclinical studies, but clinical evidence for cardiovascular applications remains limited.
People interested in CBD's medical potential, cardiac patients exploring complementary options, and healthcare providers following cannabinoid research
What the researchers found
CBD demonstrates potential anti-inflammatory, antioxidant, and vasodilatory properties relevant to pericarditis, ischemic heart disease, heart failure, and cardiac arrhythmias, with preliminary trials showing promise for recurrent pericarditis.
Why it matters
Heart disease remains the leading cause of death globally, and CBD's unique anti-inflammatory profile — without immunosuppressive effects — could fill a gap in treating inflammatory cardiac conditions.
The numbers in context
Review covered evidence on CBD's role across multiple cardiovascular conditions including ischemia-reperfusion injury, myocardial fibrosis, and cardiac arrhythmias.
How the study worked
Narrative review from Mayo Clinic researchers integrating preclinical and emerging clinical evidence on CBD in cardiovascular disease management.
What this study cannot tell us
Most evidence comes from preclinical models; limited human clinical trials, dosing inconsistencies, and regulatory challenges hinder translation to clinical practice.
How to read the evidence
Comprehensive narrative review from a leading medical institution, but limited by the scarcity of human clinical trials and dosing standardization.
When this study was published
Published in 2026 in Mayo Clinic Proceedings, reflecting cutting-edge cardiovascular cannabinoid research.
The bigger picture
If clinical trials confirm preclinical findings, CBD could become a nonimmunosuppressive therapy option for inflammatory heart conditions — a category with few current alternatives.
Questions still open
- What are the optimal CBD doses for cardiovascular benefit? How do CBD drug interactions affect cardiac medications? Can large-scale trials validate the preclinical cardioprotective signals?
Common questions
Can CBD treat heart disease?
What heart conditions might benefit from CBD?
Read the original research
Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.
Mayo Clinic proceedings, 101(2), 297-309
Citation
Abdalla, Hesham M; Bacon, Adam; VanDolah, Hunter; Dreher, Luke; Pathangey, Girish; Abdelnabi, Mahmoud; Ibrahim, Ramzi; Pereyra, Milagros; Farina, Juan M; Luis, S Allen; Arsanjani, Reza; Ayoub, Chadi. (2026). Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.. Mayo Clinic proceedings, 101(2), 297-309. https://doi.org/10.1016/j.mayocp.2025.10.009
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk